DFDA

Surgical Shunt (e.g., VP Shunt)

Treatment for Cysticercosis

Effectiveness
95%
Safety Score
40%
Clinical Trials
100
Participants
15K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
40
DangerousModerateSafe
Treatment Details
Time to Effect
Immediate
Treatment Duration
Lifetime (requires revisions)
Evidence Quality
MODERATE
Number Needed to Treat (NNT)
1(Treat 1 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
5(Treat 5 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$750
Side Effect Mgmt:$2,000
Total Annual:$7,250
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
QALYs Gained
10
Outcome-Based Costs
Cost per Responder
$8,055.5
Surgical Shunt (e.g., VP Shunt) Outcomes

for Cysticercosis

Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+90%
Common Side Effects
Shunt Malfunction
+25%
Infection
+10%
Hemorrhage
+3%
Overdrainage
+7%

Sources:

nih.gov
nih.gov
semanticscholar.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov